Scientific Focus Area
• Neurotrophic factors, cell replacement and gene-based therapeutic strategies for treatment of Parkinson’s disease.
• Experimental stem cell research with particular focus on mechanisms stimulating dopaminergic differentiation of human neural stem cells and induced pluripotent stem (iPS) cells.
• Investigation of early cellular changes that underlie the onset of neurodegeneration in
Parkinson’s disease using genetically engineered and patient-derived iPS cells.